A Rare Access Site Complication after Transcatheter Aortic Valve Implantation

  • Hakan Gocer Mail Department of Cardiology Medical Park Usak Hospital, Usak, Turkey.
  • Mohammed Abusharekh Department of Cardiology, Medical Park Izmir Hospital, İzmir, Turkey.
  • Ertugrul Ercan Department of Cardiology, Medical Park Izmir Hospital, İzmir, Turkey.
  • Istemihan Tengiz Department of Cardiology, Medical Park Izmir Hospital, İzmir, Turkey.
Transcatheter aortic valve replacement, Intestinal perforation, Colectomy


In the majority of patients undergoing transcatheter aortic valve implantation, the transfemoral access is the suggested approach due to its less invasive nature and feasibility in patients with suitable vascular anatomy. The complications of the transfemoral access site are generally vascular; however, we herein present a rare case of colon perforation following the transfemoral procedure owing to prior abdominal surgery. A transfemoral aortic valve was inserted on account of severe aortic stenosis and a high probability of surgical mortality. The patient developed acute abdomen following the procedure. Hemicolectomy was performed because of colonic perforation caused by femoral catheterization. The patient was well at 3 months’ follow-up.


1. Généreux P, Head SJ, Van Mieghem NM, Kodali S, Kirtane AJ, Xu K, Smith C, Serruys PW, Kappetein AP, Leon MB. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol 2012;59:2317-2326.
2. Fujihara S, Mori H, Kobara H, Nishiyama N, Kobayashi M, Oryu M, Masaki T. An iatrogenic sigmoid perforation caused by an aortobifemoral graft mimicking an advanced colon cancer. Intern Med 2013;52:355-357.
3. Siontis GC, Praz F, Pilgrim T, Mavridis D, Verma S, Salanti G, Søndergaard L, Jüni P, Windecker S. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J 2016;37:3503-3512.
4. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, Kodali SK, Makkar RR, Fontana GP, Kapadia S, Bavaria J, Hahn RT, Thourani VH, Babaliaros V, Pichard A, Herrmann HC, Brown DL, Williams M, Akin J, Davidson MJ, Svensson LG; PARTNER 1 trial investigators. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015;385:2477-2484.
5. Marquis-Gravel G, Tremblay-Gravel M, Lévesque J, Généreux P, Schampaert E, Palisaitis D, Doucet M, Charron T, Terriault P, Tessier P. Ultrasound guidance versus anatomical landmark approach for femoral artery access in coronary angiography: a randomized controlled trial and a meta-analysis. J Interv Cardiol 2018;31:496-503.
How to Cite
Gocer H, Abusharekh M, Ercan E, Tengiz I. A Rare Access Site Complication after Transcatheter Aortic Valve Implantation. J Tehran Heart Cent. 14(4):187-190.
Case Report(s)